🇺🇸 FDA
Pipeline program

POMALIDOMIDE, POMALIDOMIDE, POMALIDOMIDE, POMALIDOMIDE, DARZALEX 1800 mg solution for injection, DEXAMETHASONE, DEXAMETHASONE

EAE127

Phase 2 small_molecule active

Quick answer

POMALIDOMIDE, POMALIDOMIDE, POMALIDOMIDE, POMALIDOMIDE, DARZALEX 1800 mg solution for injection, DEXAMETHASONE, DEXAMETHASONE for Relapsed/refractory multiple myeloma is a Phase 2 program (small_molecule) at Ology Bioservices Ireland LTD with 1 ClinicalTrials.gov record(s).

Program details

Company
Ology Bioservices Ireland LTD
Indication
Relapsed/refractory multiple myeloma
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials